Search Results 551-560 of 18242 for Immunode

1. A Study to Evaluate the Effectiveness, Safety, and Tolerability of BOS-589 in the Treatment of Patients with Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) - Mayo Clinic

   Human immunodeficiency virus (HIV)-1 or HIV-2 antibody positive. Prior/Concomitant Therapy. Within 14 days of randomization, patient has used either of the ...

2. Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Carboplatin in Stage IIIB/IV Non-Small Cell Lung Cancer or Nab-Paclitaxel in Recurrent Metastatic Breast Cancer - Mayo Clinic

   Subject has any history of testing positive for Human Immunodeficiency Virus (HIV) or known acquired immunodeficiency disorder (AIDS). Subject has ...

3. A Study Comparing Tarlatamab, Durvalumab, Carboplatin, And Etoposide Versus Durvalumab, Carboplatin, And Etoposide In First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) - Mayo Clinic

   * Presence of active human immunodeficiency virus (HIV) or active Hepatitis (B/C) infection. * Evidence or interstitial lung disease (ILD) or active, non ...

4. A Study to Evaluate the Effectiveness, Safety and Way in Which the Body Processes REGN3500 in Adults with Moderate-to-Severe Atopic Dermatitis - Mayo Clinic

   History of human immunodeficiency virus (HIV) infection or positive HIV serology at screening. Positive with hepatitis B surface antigen (HBsAg), hepatitis ...

5. A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an Anti-PD-1 Monoclonal Antibody, in Patients With Advanced Solid Tumors - Mayo Clinic

   Immunodeficiency or is receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to the first dose of study ...

6. A Study To Assess The Safety, Tolerability, And Pharmacokinetics Of ABSK-011 In Patients With Advanced Solid Tumor - Mayo Clinic

   History of immunodeficiency, including HIV serum test positive, or other acquired/congenital immunodeficiency disease, or active tuberculosis. Any other ...

7. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Co-Administration of ABT-493 and ABT-530 With and Without RBV in Subjects With Chronic Hepatitis C Virus (HCV) Genotypes 2, 3, 4, 5 or 6 Infection - Mayo Clinic

   Positive test result at Screening for hepatitis B surface antigen (HBsAg) or anti-human immunodeficiency virus antibody (HIV Ab). HCV genotype performed ...

8. SGI-110 in Patients with Myelodysplastic Syndromes (MDS) or Acute Myelogenous Leukemia (AML) - Mayo Clinic

   Known history of human immunodeficiency virus (HIV) or active infection with hepatitis C virus (HCV) or hepatitis B virus (HBV). Hypersensitivity to ...

9. A Study to Evaluate the Safety and Effectiveness of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Are infected with human immunodeficiency virus (HIV);; QuantiFERON®-TB test or Purified Protein Derivative (PPD) skin test, or both, according to local ...

10. Study of TJ011133 in Participants With Relapsed/ Refractory Advanced Solid Tumors and Lymphoma - Mayo Clinic

    Has a diagnosis of immunodeficiency (known active human immunodeficiency virus, hepatitis B virus/hepatitis C virus infection) or is receiving chronic ...